Skip to main content
FinSpry Logo
FinSpry
ABBV logo
ABBV
(NYSE)
AbbVie Inc.
$250.91-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

AbbVie Inc. (ABBV) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for AbbVie Inc. stock.

Analyst Consensus Rating

Investment consensus from 47 professional research analysts

Consensus Rating

Buy
Based on 47 unique analysts
(63 total ratings in last 90 days)
Very High Confidence38.0:1 Buy/Sell

Average Price Target

$276.77
↑ 10.31% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest ABBV Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Keith Speights
The Motley Fool
BuyInitiates Coverage
-
Zacks Equity Research
Zacks Equity Research
HoldInitiates Coverage
-
Urmimala Biswas
Zacks Equity Research
HoldInitiates Coverage
-
DidYouReadThis
StockTwits
BuyInitiates Coverage
-
tr3ndo
StockTwits
BuyInitiates Coverage
-
Brendan Coffey
The Motley Fool
BuyInitiates Coverage
-
SellasgpsCurativeBAT11
StockTwits
BuyInitiates Coverage
-
Sundeep Ganoria
Zacks Equity Research
HoldInitiates Coverage
-
James Halley
The Motley Fool
BuyInitiates Coverage
-
Prosper Junior Bakiny
The Motley Fool
BuyInitiates Coverage
-
UK
Investing.com
BuyInitiates Coverage
-
Emily Field
Barclays
BuyReiterates
$300.00
Gavin Clark-Gartner
Evercore ISI Group
BuyInitiates Coverage
$246.00 → $260.00
Kinjel Shah
Zacks Equity Research
SellInitiates Coverage
-
Luisa Hector
Berenberg Bank
BuyMaintains
$275.00
Hans Engel
Erste
BuyDowngrades
-
Gary Nachman
Canaccord Genuity
BuyReiterates
$282.00 → $290.00
Vamil Divan
Guggenheim
BuyReiterates
$261.00 → $288.00
Terence Flynn
Morgan Stanley
BuyInitiates Coverage
$278.00 → $296.00
FlyingChemist01
StockTwits
BuyInitiates Coverage
-
Eric Volkman
The Motley Fool
BuyInitiates Coverage
-
Carter Gould
Cantor Fitzgerald
BuyMaintains
$265.00 → $285.00
Matt Phipps
William Blair
BuyReiterates
-
Jason Gerberry
BofA Securities
BuyMaintains
$234.00 → $276.00
Trung Huynh
RBC Capital
BuyMaintains
$280.00
Leo Sun
The Motley Fool
BuyInitiates Coverage
-
Deepanwita Sarkar Saha
Zacks Equity Research
BuyInitiates Coverage
-
gracie33
StockTwits
BuyInitiates Coverage
-
Courtney Breen
Bernstein
HoldMaintains
$225.00
Asad Haider
Goldman Sachs
HoldMaintains
$244.00
David Jagielski, CPA
The Motley Fool
BuyInitiates Coverage
-
David Amsellem
Piper Sandler
BuyReiterates
$298.00
Evan Seigerman
BMO Capital
BuyMaintains
$258.00 → $300.00
Michael Yee
UBS
HoldReiterates
$230.00 → $260.00
Nauman Khan
InvestorPlace
BuyInitiates Coverage
-
Tim Anderson
BofA Securities
BuyMaintains
$234.00 → $276.00
Mohit Bansal
Wells Fargo
BuyReiterates
$260.00 → $295.00
Michael Harvey
RBC Capital
BuyReiterates
$260.00 → $280.00
Vamil Divan
Guggenheim
BuyReiterates
$249.00 → $261.00
Chris Schott
JP Morgan
BuyReiterates
$260.00 → $280.00
Google Drug Manufacturers - General
TipRanks - Google
BuyDowngrades
$288.00 → $282.00
PerPlexity Drug Manufacturers - General
TipRanks - PerPlexity
BuyReiterates
$291.00 → $284.00
Anthropic Drug Manufacturers - General
TipRanks - Anthropic
HoldReiterates
$265.00 → $259.00
DeepSeek Drug Manufacturers - General
TipRanks - DeepSeek
HoldReiterates
$280.00 → $273.00
Louise Chen
Scotiabank
BuyMaintains
$280.00
Carter Gould
Cantor Fitzgerald
BuyMaintains
$240.00 → $265.00
Rajesh Kumar
HSBC
BuyMaintains
$275.00 → $300.00
David Amsellem
Piper Sandler
BuyReiterates
$298.00
Emily Field
Barclays
BuyMaintains
$275.00
Gary Nachman
Canaccord Genuity
BuyReiterates
$265.00 → $273.00
Tyler Van Buren
TD Cowen
BuyReiterates
$280.00
Jason Gerberry
BofA Securities
BuyMaintains
$234.00
Geoff Meacham
Citi
BuyMaintains
$230.00
Mohit Bansal
Wells Fargo
BuyInitiates Coverage
$260.00
Terence Flynn
Morgan Stanley
BuyMaintains
$270.00 → $278.00
Matt Phipps
William Blair
BuyReiterates
-
Asad Haider
Goldman Sachs
HoldMaintains
$244.00
Jason Gerberry
BofA Securities
BuyMaintains
$234.00
Trung Huynh
RBC Capital
BuyMaintains
$260.00
Terence Flynn
Morgan Stanley
BuyMaintains
$270.00 → $278.00
Evan Seigerman
BMO Capital
BuyMaintains
$258.00
Chris Schott
JP Morgan
BuyMaintains
-
Michael Yee
UBS
HoldMaintains
$230.00

Frequently Asked Questions

What is the analyst consensus rating for ABBV?

The analyst consensus rating for ABBV is "Buy" based on 47 analyst recommendations.

What is the average price target for ABBV?

The average 12-month price target for ABBV is $276.77, representing an upside of 10.3% from the current price of $250.91.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.